Catalyst Pharmaceuticals Inc (CPRX)
21.80
-0.09
(-0.41%)
USD |
NASDAQ |
Nov 04, 13:04
Catalyst Pharmaceuticals Max Drawdown (5Y): 64.87% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 64.87% |
| September 30, 2024 | 64.87% |
| August 31, 2024 | 64.87% |
| July 31, 2024 | 64.87% |
| June 30, 2024 | 64.87% |
| May 31, 2024 | 64.87% |
| April 30, 2024 | 64.87% |
| March 31, 2024 | 64.87% |
| February 29, 2024 | 64.87% |
| January 31, 2024 | 64.87% |
| December 31, 2023 | 64.87% |
| November 30, 2023 | 64.87% |
| October 31, 2023 | 64.87% |
| September 30, 2023 | 66.55% |
| August 31, 2023 | 66.55% |
| July 31, 2023 | 66.55% |
| June 30, 2023 | 66.55% |
| May 31, 2023 | 66.55% |
| April 30, 2023 | 66.55% |
| March 31, 2023 | 66.55% |
| February 28, 2023 | 66.55% |
| January 31, 2023 | 66.55% |
| December 31, 2022 | 66.55% |
| November 30, 2022 | 66.55% |
| October 31, 2022 | 66.55% |
| Date | Value |
|---|---|
| September 30, 2022 | 66.55% |
| August 31, 2022 | 66.55% |
| July 31, 2022 | 66.55% |
| June 30, 2022 | 66.55% |
| May 31, 2022 | 66.55% |
| April 30, 2022 | 66.55% |
| March 31, 2022 | 66.55% |
| February 28, 2022 | 70.56% |
| January 31, 2022 | 71.43% |
| December 31, 2021 | 80.66% |
| November 30, 2021 | 80.84% |
| October 31, 2021 | 81.01% |
| September 30, 2021 | 82.23% |
| August 31, 2021 | 83.28% |
| July 31, 2021 | 83.28% |
| June 30, 2021 | 83.45% |
| May 31, 2021 | 87.28% |
| April 30, 2021 | 87.46% |
| March 31, 2021 | 89.36% |
| February 28, 2021 | 90.33% |
| January 31, 2021 | 90.33% |
| December 31, 2020 | 90.33% |
| November 30, 2020 | 90.33% |
| October 31, 2020 | 90.33% |
| September 30, 2020 | 90.33% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
64.87%
Minimum
Oct 2023
90.33%
Maximum
Nov 2019
75.56%
Average
66.55%
Median
Mar 2022
Max Drawdown (5Y) Benchmarks
| Sarepta Therapeutics Inc | 64.93% |
| Vertex Pharmaceuticals Inc | 41.60% |
| Regenxbio Inc | 84.15% |
| Edgewise Therapeutics Inc | -- |
| Entrada Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 23.65 |
| Beta (5Y) | 0.7537 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 57.54% |
| Historical Sharpe Ratio (5Y) | 0.5801 |
| Historical Sortino (5Y) | 1.055 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.94% |